Russell Investments Group’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$137K Buy
7,702
+5,319
+223% +$66.4K ﹤0.01% 3325
2026
Q1
$21.7K Buy
2,383
+3
+0.1% +$38 ﹤0.01% 3603
2025
Q4
$32.6K Buy
2,380
+22
+0.9% +$408 ﹤0.01% 3461
2025
Q3
$51.4K Buy
2,358
+2,158
+1,079% +$25.4K ﹤0.01% 3282
2025
Q2
$2.39K Hold
200
﹤0.01% 3573
2025
Q1
$2.38K Hold
200
﹤0.01% 3487
2024
Q4
$3.08K Hold
200
﹤0.01% 3369
2024
Q3
$2.24K Sell
200
-68
-25% -$651 ﹤0.01% 3357
2024
Q2
$1.45K Sell
268
-46,028
-99% -$266K ﹤0.01% 3391
2024
Q1
$315K Buy
46,296
+46,096
+23,048% +$322K ﹤0.01% 2349
2023
Q4
$1.36K Buy
+200
New +$1.13K ﹤0.01% 3039

Other funds holding CLPT

Russell Investments Group's CLPT Position: Q2 2026 in Review

Russell Investments Group increased its ClearPoint Neuro (CLPT) stake by 223% in Q2 2026, buying an estimated $66.4K and bringing the position to 7,702 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #3325.

Russell Investments Group first reported a position in CLPT in Q4 2023 and has held it in 11 quarters since. The position peaked at $315K in Q1 2024. 49 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Russell Investments Group held 7,702 shares of ClearPoint Neuro worth $137K as of Q2 2026.
  • Russell Investments Group bought 5,319 ClearPoint Neuro shares in Q2 2026, an estimated $66.4K.
  • ClearPoint Neuro made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3325 holding.
  • Russell Investments Group first reported a position in ClearPoint Neuro in Q4 2023 and has held it in 11 quarters since.
  • Russell Investments Group's ClearPoint Neuro position peaked at $315K in Q1 2024.
  • 49 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.